Print page
Email page
Quotes delayed at least 20 minutes.
Information provided by TurboFeed.
|
|
|
|
|
 = Add Release to Briefcase |
| All Releases |
|---|
 |
XOMA Reports First Quarter 2008 Financial Results
May 12, 2008
|
33.4 KB
|
| |
BERKELEY, Calif., May 12, 2008 (PrimeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced its results for the quarter ended March 31, 2008.
"XOMA made excellent progress during the first quarter, including the advancement of two clinical trials of XOMA...
|
|
|
XOMA Refinances Royalty-Based Loan Facility for $55 Million
May 12, 2008
|
12.3 KB
|
| |
BERKELEY, Calif., May 12, 2008 (PrimeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that it has entered into an amended loan facility under which it has borrowed $55 million from Goldman Sachs Specialty Lending Group, L.P. (Goldman Sachs). The loan is...
|
|
|
XOMA to Announce First Quarter 2008 Financial Results and Host Conference Call on Monday, May 12
May 5, 2008
|
11.1 KB
|
| |
BERKELEY, Calif., May 5, 2008 (PrimeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced that the Company will host a conference call and webcast on Monday, May 12, 2008 at 8:30 a.m. Eastern time to discuss first quarter 2008 financial results and provide a gener...
|
|
|
XOMA Announces New Audit Committee Member
Apr 1, 2008
|
10.2 KB
|
| |
BERKELEY, Calif., Apr 1, 2008 (PrimeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA) announced today that XOMA's Board of Directors has appointed Board member William K. Bowes, Jr. to its Audit Committee. The appointment follows the recent passing of James G. Andress, a member of XOMA's Board of Directors and its Audit Committee.
XO...
|
|
|
XOMA to Present At Cowen Health Care Conference On March 17
Mar 12, 2008
|
10.8 KB
|
| |
BERKELEY, Calif., Mar 12, 2008 (PrimeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief Executive Officer of XOMA, is scheduled to present at the Cowen and Company Health Care Conference. The presentation will take pl...
|
|
|
XOMA Reports 2007 Results
Mar 11, 2008
|
33.1 KB
|
| |
BERKELEY, Calif., Mar 11, 2008 (PrimeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, today announced its results for the year ended December 31, 2007.
"In 2007, our revenues more than doubled as a result of the Company's success in establishing a vibrant business ...
|
|
|
XOMA Appoints Mary L. Anderson as Vice President of Business Development
Mar 10, 2008
|
11.3 KB
|
| |
BERKELEY, Calif., Mar 10, 2008 (PrimeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, today appointed Mary L. Anderson as Vice President of Business Development. Ms. Anderson will oversee XOMA's business development initiatives, including licensing activities related t...
|
|
|
XOMA to Announce 2007 Financial Results and Host Conference Call On Tuesday, March 11
Mar 4, 2008
|
11.0 KB
|
| |
BERKELEY, Calif., Mar 4, 2008 (PrimeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced that the Company will host a conference call and webcast on Tuesday, March 11, 2008 at 4:30 p.m. Eastern time to discuss 2007 financial results and provide a general business...
|
|
|
XOMA to Present At Susquehanna Financial Group Healthcare Conference On March 4
Feb 27, 2008
|
10.7 KB
|
| |
BERKELEY, Calif., Feb 27, 2008 (PrimeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief Executive Officer of XOMA, is scheduled to present at Susquehanna Financial Group's Second Annual SIGnificant Options in Healthca...
|
|
|
XOMA to Present At BIO CEO and Investor Conference On February 11
Feb 4, 2008
|
10.7 KB
|
| |
BERKELEY, Calif., Feb 4, 2008 (PrimeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief Executive Officer of XOMA, is scheduled to present at the BIO CEO and Investor Conference. The presentation will take place in New...
|
|
|
XOMA Appoints W. Denman Van Ness as Lead Independent Director
Jan 18, 2008
|
10.4 KB
|
| |
BERKELEY, Calif., Jan 18, 2008 (PrimeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that its Board of Directors has appointed current board member W. Denman ("Denny") Van Ness as Lead Independent Director.
Steven Engle, Chairman and Chief Executiv...
|
|
|
XOMA Speaks On Diabetes and Obesity Panel At RBC Capital Markets Healthcare Conference
Dec 6, 2007
|
11.1 KB
|
| |
BERKELEY, Calif., Dec 6, 2007 (PrimeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief Executive Officer of XOMA, is scheduled to present at the 2007 RBC Capital Markets Healthcare Conference. The presentation is part...
|
|
|
XOMA Announces Conference Call to Provide Overview of Business Strategy
Nov 26, 2007
|
14.2 KB
|
| |
BERKELEY, Calif., Nov 26, 2007 (PrimeNewswire via COMTEX News Network) -- XOMA, Ltd., (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, today will host a conference call and live webcast to discuss its business strategy including an overview of its clinical development plans and 2008 outlook.
The conference call...
|
|
|
XOMA to Present At Lazard Capital Markets Healthcare Conference On November 27
Nov 15, 2007
|
9.4 KB
|
| |
BERKELEY, Calif., Nov 15, 2007 (PrimeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief Executive Officer of XOMA, is scheduled to present at the Lazard Capital Markets Fourth Annual Healthcare Conference. The present...
|
|
|
XOMA Reports Third Quarter 2007 Financial Results
Nov 8, 2007
|
28.0 KB
|
| |
BERKELEY, Calif., Nov 8, 2007 (PrimeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced its results for the quarter ended September 30, 2007.
"XOMA's successful third quarter highlights the value of our antibody discovery and development technologies ...
|
|
|
XOMA to Announce Third Quarter 2007 Financial Results and Host Conference Call On Thursday, November 8
Nov 1, 2007
|
10.6 KB
|
| |
BERKELEY, Calif., Nov 1, 2007 (PrimeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced that the Company will host a conference call and webcast on Thursday, November 8, 2007 at 8:30 a.m. Eastern time to discuss third quarter 2007 financial results and provide a...
|
|
|
XOMA to Present at Acumen BioFin Rodman & Renshaw Healthcare Conference
Oct 30, 2007
|
9.4 KB
|
| |
BERKELEY, Calif., Oct 30, 2007 (PrimeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief Executive Officer of XOMA, is scheduled to present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference. The pr...
|
|
|
Steven Engle Appointed Chairman of XOMA
Oct 8, 2007
|
9.9 KB
|
| |
BERKELEY, Calif., Oct 8, 2007 (PrimeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, today announced the appointment of its Chief Executive Officer and President, Steven Engle, as Chairman of the Board of Directors effective October 5, 2007. Mr. Engle joined XOMA as it...
|
|
|
XOMA to Present At 2007 BIO Investor Forum
Oct 3, 2007
|
9.3 KB
|
| |
BERKELEY, Calif., Oct 3, 2007 (PrimeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, XOMA's Chief Executive Officer and President, is scheduled to present at the 2007 BIO Investor Forum. The presentation will take place on Wednesday, ...
|
|
|
XOMA Initiates Phase 1 European Trial in Diabetes for XOMA 052, a Novel Anti-IL-1 Antibody Designed to Target Diabetes, Rheumatoid Arthritis and Other Inflammatory Diseases
Sep 12, 2007
|
14.1 KB
|
| |
BERKELEY, Calif., Sep 12, 2007 (PrimeNewswire via COMTEX News Network) -- XOMA Ltd. (Nasdaq:XOMA) today announced the start of a second Phase 1 clinical study of XOMA 052, a potent monoclonal antibody targeting Interleukin-1 beta (IL-1 beta), in patients with Type 2 diabetes. IL-1 plays a role in multiple inflammatory diseases and has been implicat...
|
|
|
|
©XOMA 2006